Accumulation of genomic aberrations during clinical progression of medulloblastoma

[1]  Axel Benner,et al.  Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  P. Lichter,et al.  Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas , 2007, Genes, chromosomes & cancer.

[3]  W. Hartmann,et al.  Prognostic Relevance of Clinical and Biological Risk Factors in Childhood Medulloblastoma: Results of Patients Treated in the Prospective Multicenter Trial HIT'91 , 2007, Clinical Cancer Research.

[4]  N. Tarbell,et al.  Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification , 2007, Nature Clinical Practice Oncology.

[5]  D. Ellison,et al.  Wnt/Wingless Pathway Activation and Chromosome 6 Loss Characterise a Distinct Molecular Sub-Group of Medulloblastomas Associated with a Favourable Prognosis , 2006, Cell cycle.

[6]  H. Min,et al.  Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior , 2006, Acta Neuropathologica.

[7]  P. Kleihues,et al.  Stratification of medulloblastoma on the basis of histopathological grading , 2006, Acta Neuropathologica.

[8]  T. Curran,et al.  Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Axel Benner,et al.  Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Claire L Weston,et al.  beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Chiò,et al.  Anaplasia Is Rare and Does Not Influence Prognosis in Adult Medulloblastoma , 2005, Journal of neuropathology and experimental neurology.

[12]  J. Biegel,et al.  Isochromosome 17q Is a Negative Prognostic Factor in Poor-Risk Childhood Medulloblastoma Patients , 2005, Clinical Cancer Research.

[13]  J. Rutka,et al.  A Clinicobiological Model Predicting Survival in Medulloblastoma , 2004, Clinical Cancer Research.

[14]  D. Ellison,et al.  Combined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma Patients , 2004, Clinical Cancer Research.

[15]  C. Dang,et al.  Histopathological and Molecular Prognostic Markers in Medulloblastoma: c‐myc, N‐myc, TrkC, and Anaplasia , 2004, Journal of neuropathology and experimental neurology.

[16]  F. Kokocinski,et al.  Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. , 2004, Cancer research.

[17]  Amar Gajjar,et al.  Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Burger,et al.  Anaplasia and Grading in Medulloblastomas , 2003, Brain pathology.

[19]  D. Ellison,et al.  Morphophenotypic Variation Predicts Clinical Behavior in Childhood Non‐Desmoplastic Medulloblastomas , 2003, Journal of neuropathology and experimental neurology.

[20]  P. Burger,et al.  Medulloblastomas With Systemic Metastases: Evaluation of Tumor Histopathology and Clinical Behavior in 23 Patients , 2003, Journal of pediatric hematology/oncology.

[21]  P. Burger,et al.  Histopathologic grading of medulloblastomas , 2002, Cancer.

[22]  P. Burger,et al.  Comparative Genomic Hybridization Detects An Increased Number of Chromosomal Alterations in Large Cell/Anaplastic Medulloblastomas , 2002, Brain pathology.

[23]  J. Crolla,et al.  Clinical and molecular stratification of disease risk in medulloblastoma , 2001, British Journal of Cancer.

[24]  L. Rorke,et al.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Joos,et al.  Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  L. Rorke,et al.  Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. , 1996, Neurosurgery.

[27]  R. Gelber,et al.  Prognostic factors in medulloblastoma, including DNA ploidy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.